Atara Biotherapeutics (STU:AT2) Price-to-Operating-Cash-Flow : (As of May. 27, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Atara Biotherapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-27), Atara Biotherapeutics's share price is €0.5702. Atara Biotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.54. Hence, Atara Biotherapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Atara Biotherapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:AT2's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Atara Biotherapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.19. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.54.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -8.00% per year.

During the past 12 years, Atara Biotherapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 16.90% per year. The lowest was -68.60% per year. And the median was 5.05% per year.

Atara Biotherapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Atara Biotherapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Price-to-Operating-Cash-Flow Chart

Atara Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Atara Biotherapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Atara Biotherapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Atara Biotherapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atara Biotherapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Price-to-Operating-Cash-Flow falls into.

Atara Biotherapeutics Price-to-Operating-Cash-Flow Calculation

Atara Biotherapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.5702	/	-1.537
	=

Atara Biotherapeutics's Share Price of today is €0.5702.
Atara Biotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.54.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Atara Biotherapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Atara Biotherapeutics (STU:AT2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (STU:AT2) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT2:Germany

Address

2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (STU:AT2) Headlines

No Headlines